© 2019 The Sonder Group

The biotech job market continues to be strong – good news for companies and employees. Companies are hiring and for the first time in years, I am seeing candidates with multiple competitive offers. It is always important to find the best candidates for your teams, but in competitive markets finding “A” players and taking the time to find the right fit is imperative. There are a variety of hiring guides available but one that I highly recommend is, “Who, the A Method for Hiring” by Geoff Smart and Randy Street. It is an easy airplane r...

I had the pleasure of attending the two day GoldLab Symposium 2015 in Boulder, CO. The annual event seeks to bring together critical thinkers in bioscience, medicine, public policy, and the humanities to discuss complexities and barriers for improving health care. Its mission is to build an informed community of scientists, public influencers, and other stakeholders to bring light to the nation’s healthcare crisis and provide exciting concepts as potential solutions.

The symposium is the brain child of Larry Gold, Professor at The Univ...

In case you haven’t heard, the Sonder Group relocated to San Francisco a month ago. Although this signals some big changes, our mission remains unchanged: retained & contingency searches across North America and Western Europe for early stage and growing life science companies. We are continuing to recruit leadership positions ranging from “C” level to managers for R&D, Manufacturing, Sales, Marketing, Product Managers, Field Applications, and Scientific Advisors. San Francisco and Boston are Biotech hubs so even though Karen is now o...

My first brush with Synthetic Biology, 13 years ago, was a baptism by fire, but exciting nonetheless. It was late in 2000 while I was working as part of the NewcoGen Group (a Flagship Ventures fund) where we founded a synthetic biology company called engeneOS (Engineered Genomic Operating Systems). The business plan included innovative but optimistic strategies to develop engineered genomic parts that could be assembled to provide bio-organisms with a range of novel properties. We also envisioned assembly of whole modified organisms,...

Please reload

Categories
Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Facebook Social Icon